Peptide YY levels are elevated after gastric bypass surgery

Area of Science:

• Endocrinology
• Bariatric Surgery
• Metabolic Disorders

Background:

• Roux-en-Y gastric bypass (RYGB) is effective for sustained weight loss.
• Mechanisms underlying RYGB efficacy, particularly appetite regulation, are not fully understood.
• Gut-derived hormones like Peptide YY (PYY) play a role in appetite control.

Purpose of the Study:

• To investigate the impact of RYGB on PYY levels and response to glucose.
• To compare PYY and ghrelin levels in post-RYGB patients with obese and lean controls.

Main Methods:

• Measured PYY and ghrelin levels during an oral glucose tolerance test.
• Included 6 morbidly obese patients 1.5 years post-RYGB, 12 obese controls, and 5 lean controls.

Main Results:

• Post-RYGB patients exhibited a significantly higher PYY response to glucose (10-fold increase) compared to controls (2-fold increase).
• PYY levels remained elevated for extended periods post-glucose load in RYGB patients.
• Ghrelin levels decreased post-RYGB in a manner inversely related to PYY levels.

Conclusions:

• RYGB surgery induces a robust PYY response to caloric intake, potentially contributing to sustained weight loss.
• Combined effects of increased PYY and decreased ghrelin may mediate appetite changes after RYGB.
• Findings support further research into PYY(3-36) as a potential obesity therapy.